# Emergent BioSolutions Inc.: Form 8-K, filed Aug 5, 2019

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2019-08-05
- Accepted by EDGAR: Aug 5, 2019, 17:04 ET
- Period: 2019-07-30
- Accession: 0001367644-19-000040
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764419000040/av7909optionexercisean.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764419000040/

## Items reported

- Item 1.02: Termination of a material agreement
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764419000040/av7909optionexercisean.htm

Filed Aug 5, 2019.
Source: SEC EDGAR, the filing index for accession 0001367644-19-000040. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
